Business Description
Shandong Weigao Group Medical Polymer Co Ltd
NAICS : 339112
ISIN : CNE100000171
Share Class Description:
FRA:UK2: Class HCompare
Compare
Traded in other countries / regions
01066.Hong KongSHWGY.USAUK2.Germany IPO Date
2004-03-31Description
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.91 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | 1.62 | |||||
| Interest Coverage | 8.25 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.99 | |||||
| Beneish M-Score | -2.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.5 | |||||
| 3-Year EBITDA Growth Rate | -1.9 | |||||
| 3-Year EPS without NRI Growth Rate | -1.9 | |||||
| 3-Year FCF Growth Rate | 2.8 | |||||
| 3-Year Book Growth Rate | 4.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 6.26 | |||||
| Future 3-5Y Total Revenue Growth Rate | 4.82 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.79 | |||||
| 9-Day RSI | 43.81 | |||||
| 14-Day RSI | 46.36 | |||||
| 6-1 Month Momentum % | 5 | |||||
| 12-1 Month Momentum % | -35.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.28 | |||||
| Quick Ratio | 2.89 | |||||
| Cash Ratio | 1.32 | |||||
| Days Inventory | 133.75 | |||||
| Days Sales Outstanding | 203.43 | |||||
| Days Payable | 209.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.51 | |||||
| Dividend Payout Ratio | 0.41 | |||||
| 3-Year Dividend Growth Rate | 4.8 | |||||
| Forward Dividend Yield % | 4.54 | |||||
| 5-Year Yield-on-Cost % | 7.23 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | 6.28 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.93 | |||||
| Operating Margin % | 16.77 | |||||
| Net Margin % | 14.73 | |||||
| FCF Margin % | 20.86 | |||||
| ROE % | 8.46 | |||||
| ROA % | 5.59 | |||||
| ROIC % | 8.7 | |||||
| ROC (Joel Greenblatt) % | 20 | |||||
| ROCE % | 9.22 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 10.34 | |||||
| Forward PE Ratio | 8.26 | |||||
| PE Ratio without NRI | 10.13 | |||||
| Shiller PE Ratio | 9.71 | |||||
| Price-to-Owner-Earnings | 9 | |||||
| PEG Ratio | 1.51 | |||||
| PS Ratio | 1.49 | |||||
| PB Ratio | 0.83 | |||||
| Price-to-Tangible-Book | 1.07 | |||||
| Price-to-Free-Cash-Flow | 7.09 | |||||
| Price-to-Operating-Cash-Flow | 7.09 | |||||
| EV-to-EBIT | 6.67 | |||||
| EV-to-Forward-EBIT | 6.52 | |||||
| EV-to-EBITDA | 6.67 | |||||
| EV-to-Forward-EBITDA | 5.4 | |||||
| EV-to-Revenue | 1.3 | |||||
| EV-to-Forward-Revenue | 1.52 | |||||
| EV-to-FCF | 6.22 | |||||
| Price-to-Projected-FCF | 0.5 | |||||
| Price-to-DCF (Earnings Based) | 0.58 | |||||
| Price-to-DCF (FCF Based) | 0.62 | |||||
| Price-to-Median-PS-Value | 0.38 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.4 | |||||
| Price-to-Graham-Number | 0.7 | |||||
| Price-to-Net-Current-Asset-Value | 2.37 | |||||
| Earnings Yield (Greenblatt) % | 14.99 | |||||
| FCF Yield % | 14.21 | |||||
| Forward Rate of Return (Yacktman) % | 15.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shandong Weigao Group Medical Polymer Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,662.905 | ||
| EPS (TTM) (€) | 0.053 | ||
| Beta | 0.24 | ||
| Volatility % | 50.55 | ||
| 14-Day RSI | 46.36 | ||
| 14-Day ATR (€) | 0.015044 | ||
| 20-Day SMA (€) | 0.55675 | ||
| 12-1 Month Momentum % | -35.58 | ||
| 52-Week Range (€) | 0.426 - 0.83 | ||
| Shares Outstanding (Mil) | 4,507.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shandong Weigao Group Medical Polymer Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shandong Weigao Group Medical Polymer Co Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shandong Weigao Group Medical Polymer Co Ltd Frequently Asked Questions
What is Shandong Weigao Group Medical Polymer Co Ltd(FRA:UK2)'s stock price today?
The current price of FRA:UK2 is €0.55. The 52 week high of FRA:UK2 is €0.83 and 52 week low is €0.43.
When is next earnings date of Shandong Weigao Group Medical Polymer Co Ltd(FRA:UK2)?
The next earnings date of Shandong Weigao Group Medical Polymer Co Ltd(FRA:UK2) is .
Does Shandong Weigao Group Medical Polymer Co Ltd(FRA:UK2) pay dividends? If so, how much?
The Dividend Yield %  of Shandong Weigao Group Medical Polymer Co Ltd(FRA:UK2) is 4.51% (As of Today), Highest Dividend Payout Ratio of Shandong Weigao Group Medical Polymer Co Ltd(FRA:UK2) was 0.41. The lowest was 0.25. And the median was 0.29. The  Forward Dividend Yield % of Shandong Weigao Group Medical Polymer Co Ltd(FRA:UK2) is 4.54%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers